Lv5
962 积分 2022-02-18 加入
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator-controlled VOYAGE 1 trial
10小时前
已完结
Factors facilitating shared decision making in eczema: Met and unmet needs from the patient perspective
7天前
已完结
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations
11天前
已完结
中国腹膜透析管理现状白皮书
1个月前
已完结
皖公网安备34019202002308
